In this validation, five genes (RNU2-1, SCARNA2, SNORD15B, SCARNA3, and SNORD94) were confirmed to be significantly downregulated in tumor samples, while two genes (SNORA68 and SNHG1) were upregulated compared with benign samples. The gene discussed is RNU2-1; the disease is neoplasm.